OK Biotech Co., Ltd. (4155.TW)
TWD 20.9
(-0.71%)
TWD 20.9
(-0.71%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.06 Billion TWD | 0.2% |
| 2022 | 3.06 Billion TWD | 8.83% |
| 2021 | 2.81 Billion TWD | 10.95% |
| 2020 | 2.53 Billion TWD | 14.17% |
| 2019 | 2.22 Billion TWD | 19.98% |
| 2018 | 1.85 Billion TWD | -1.77% |
| 2017 | 1.88 Billion TWD | 25.99% |
| 2016 | 1.49 Billion TWD | 3.45% |
| 2015 | 1.44 Billion TWD | 2.48% |
| 2014 | 1.41 Billion TWD | -3.16% |
| 2013 | 1.45 Billion TWD | 87.29% |
| 2012 | 777.74 Million TWD | 59.89% |
| 2011 | 486.41 Million TWD | 49.49% |
| 2010 | 325.38 Million TWD | 58.98% |
| 2009 | 204.66 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 3.11 Billion TWD | 1.55% |
| 2024 Q2 | 3.55 Billion TWD | 14.05% |
| 2023 Q4 | 3.06 Billion TWD | -4.9% |
| 2023 Q2 | 2.96 Billion TWD | -3.51% |
| 2023 Q3 | 3.22 Billion TWD | 8.66% |
| 2023 FY | 3.06 Billion TWD | 0.2% |
| 2023 Q1 | 3.07 Billion TWD | 0.5% |
| 2022 Q4 | 3.06 Billion TWD | 1.85% |
| 2022 FY | 3.06 Billion TWD | 8.83% |
| 2022 Q1 | 2.74 Billion TWD | -2.32% |
| 2022 Q2 | 2.89 Billion TWD | 5.26% |
| 2022 Q3 | 3 Billion TWD | 3.92% |
| 2021 Q3 | 2.77 Billion TWD | 0.91% |
| 2021 Q4 | 2.81 Billion TWD | 1.3% |
| 2021 FY | 2.81 Billion TWD | 10.95% |
| 2021 Q1 | 2.56 Billion TWD | 1.33% |
| 2021 Q2 | 2.75 Billion TWD | 7.12% |
| 2020 Q3 | 2.57 Billion TWD | 13.82% |
| 2020 Q2 | 2.25 Billion TWD | -1.37% |
| 2020 Q4 | 2.53 Billion TWD | -1.42% |
| 2020 Q1 | 2.29 Billion TWD | 3.17% |
| 2020 FY | 2.53 Billion TWD | 14.17% |
| 2019 Q3 | 2 Billion TWD | 6.97% |
| 2019 Q4 | 2.22 Billion TWD | 10.67% |
| 2019 Q1 | 1.88 Billion TWD | 1.75% |
| 2019 Q2 | 1.87 Billion TWD | -0.41% |
| 2019 FY | 2.22 Billion TWD | 19.98% |
| 2018 Q2 | 1.96 Billion TWD | -1.5% |
| 2018 FY | 1.85 Billion TWD | -1.77% |
| 2018 Q1 | 1.99 Billion TWD | 5.83% |
| 2018 Q4 | 1.85 Billion TWD | 6.93% |
| 2018 Q3 | 1.73 Billion TWD | -11.87% |
| 2017 FY | 1.88 Billion TWD | 25.99% |
| 2017 Q4 | 1.88 Billion TWD | 15.72% |
| 2017 Q3 | 1.62 Billion TWD | -6.54% |
| 2017 Q2 | 1.74 Billion TWD | 11.13% |
| 2017 Q1 | 1.56 Billion TWD | 4.82% |
| 2016 Q4 | 1.49 Billion TWD | 0.0% |
| 2016 Q1 | - TWD | -100.0% |
| 2016 FY | 1.49 Billion TWD | 3.45% |
| 2016 Q2 | 1.57 Billion TWD | 0.0% |
| 2015 Q1 | 1.44 Billion TWD | 2.61% |
| 2015 Q3 | 1.44 Billion TWD | -0.13% |
| 2015 Q2 | 1.44 Billion TWD | 0.0% |
| 2015 FY | 1.44 Billion TWD | 2.48% |
| 2015 Q4 | 1.44 Billion TWD | 0.0% |
| 2014 Q1 | 1.51 Billion TWD | 3.98% |
| 2014 FY | 1.41 Billion TWD | -3.16% |
| 2014 Q4 | 1.41 Billion TWD | 0.0% |
| 2014 Q3 | 1.41 Billion TWD | -6.87% |
| 2014 Q2 | 1.51 Billion TWD | 0.0% |
| 2013 Q1 | 1.27 Billion TWD | 63.9% |
| 2013 Q2 | 1.27 Billion TWD | 0.0% |
| 2013 FY | 1.45 Billion TWD | 87.29% |
| 2013 Q4 | 1.45 Billion TWD | 0.0% |
| 2013 Q3 | 1.45 Billion TWD | 14.27% |
| 2012 Q4 | 777.74 Million TWD | 0.0% |
| 2012 Q2 | 565.75 Million TWD | 0.0% |
| 2012 Q3 | 777.74 Million TWD | 37.47% |
| 2012 FY | 777.74 Million TWD | 59.89% |
| 2011 FY | 486.41 Million TWD | 49.49% |
| 2011 Q2 | 353.76 Million TWD | 0.0% |
| 2011 Q4 | 486.41 Million TWD | 0.0% |
| 2010 FY | 325.38 Million TWD | 58.98% |
| 2010 Q4 | 325.38 Million TWD | 0.0% |
| 2009 FY | 204.66 Million TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Excelsior Medical Co., Ltd. | 18.07 Billion TWD | 83.034% |
| Apex Medical Corp. | 3.22 Billion TWD | 4.884% |
| Applied BioCode Corporation | 993.2 Million TWD | -208.834% |